7459
Medipal Holdings Corporation
2026/02/09
Consolidated net sales for the third quarter of the fiscal year ending March 2026 increased 3.7% year-over-year to ¥2,911,667 million, operating income decreased 4.8% to ¥43,183 million, and net income attributable to owners of parent increased 3.2% to ¥37,414 million.
